Back to
Skandinaviska Enskilda Banken AB (publ)
DRNA4 quarters
Position history for
Skandinaviska Enskilda Banken AB (publ)'s holdings in DICERNA PHARMACEUTICALS INC
As of its Q3 2021 13F, Skandinaviska Enskilda Banken AB (publ) held 6,300 shares of DRNA (Dicerna Pharmaceuticals), worth $127,000.
Final Value
$0
Final Shares
0
Total Value Change
-$711,000
Total Shares Change
-28,000
Quarter-by-Quarter History
Other major holders of DRNA: RTW INVESTMENTS, LP